Home      Contact      Sitemap     Deutsch  
 
 
Investor Relations
News
Stock Quotation
Reports
Performance Figures
Annual General Meeting
Corporate Governance
Financial Calendar
Stockholder Structure
Issuing Dates
Presentations
Research
IR Contact Form
IR Contact Person
 
 
Press Release dated March 3, 2006

 




Heraeus distributes biomaterial Ostim®

ADC Advanced Dental Care, a subsidiary of aap Implantate AG, a German medical technology company active in the areas of fracture healing, joint replacement, bone cements and biomaterials, has entered into a long-term agreement with Heraeus Kulzer GmbH for the worldwide distribution of aap´s bone graft substitute Ostim® in the dental field. Heraeus Kulzer, a subsidiary of the Heraeus Group, is a leading European supplier of dental products.

Ostim® is a synthetic nanotechnology-based, absorbable bone graft substitute. Nanostructure, revascularization and bone transformation quality of Ostim® extensively corresponds to the quality of the natural bone.

This agreement, which significantly enlarges an existing cooperation, also includes the market introduction of Ostim® in the dental field in the USA. The FDA approval required for this has already been obtained. After a one-year introductory phase, the target minimum sales volume of the cooperation is significantly above one million Euros per year for ADC and should further increase in coming years.

In October 2005 aap Implantate AG acquired 54% of ADC´s shares.







For further information, please contact:

aap Implantate AG
Lorenzweg 5
D-12099 Berlin
X
Oliver Bielenstein

Nanette Hüdepohl

Director/CFO

Investor & Public Relations

Tel.: +49 30 750 19 - 140

Tel.: +49 30 75019 - 133

Fax: +49 30 750 19 - 290

Fax: +49 30 75019 - 290

X
WKN 506660, ISIN DE0005066609
Prime Standard/Regulated Market
Traded at all German Stock Exchanges

© 2012 aap Implantate AG


Print this page